INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 226 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,787,500 | +46.6% | 150,000 | +25.0% | 0.07% | +16.4% |
| Q3 2022 | $2,584,000 | +44.3% | 119,972 | +60.0% | 0.06% | +3.4% |
| Q4 2019 | $1,791,000 | +1.5% | 75,000 | -25.0% | 0.06% | -15.7% |
| Q3 2019 | $1,764,000 | -31.1% | 100,000 | 0.0% | 0.07% | +16.7% |
| Q2 2019 | $2,560,000 | +64.0% | 100,000 | +100.0% | 0.06% | +100.0% |
| Q3 2017 | $1,561,000 | +263.9% | 50,000 | +100.0% | 0.03% | +130.8% |
| Q2 2017 | $429,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |